MarkWide Research


Auto-transfusion Systems Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: August, 2022
No of Pages: 172
Delivery Format: PDF + Excel


Description of the Report

Market Overview

The Auto-transfusion Systems Market is expected to grow at a 5.2% CAGR over the forecast period. The market’s growth can be attributed to an increase in surgical procedures. This is due to the increasing prevalence of chronic diseases and lifestyle diseases. The market is also being boosted by a shortage of allogeneic or donated blood. India reported that there were 107 countries in India with a shortage of blood. The shortfall reached 100 million units. Of these, 41 million needed to be delivered in India. The market growth is stifled by the high price of auto-transfusion devices and the risks associated with this procedure.

Auto-transfusion Systems Market Report Scope and Segmentation 
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

Scope of the Report

Auto-transfusion, per the report’s scope, is an autologous blood transfusion process in which the patient receives its blood after separation, washing and filtration. This report can be segmented according to Device Type, Application and End-User, and Geography.

By Product Type
By Application
Cardiac Surgeries
Orthopedic Surgeries
Organ Transplantation
By End-User
Ambulatory Surgical Centers

Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

The Cardiac Surgeries segment dominates the Auto-transfusion Systems Market.

The increasing incidence of heart disease and the recommendation for autologous transfusions in cardiac surgeries account for the most significant portion of this segment. World Health Organization estimates cardiovascular disease is the leading worldwide cause, claiming 17.9 million deaths yearly. American Heart Association estimates that approximately 2,300 Americans are killed daily by cardiovascular disease. This is an average of one death every 38 seconds. 92.1 million Americans suffer from some form of stroke-related cardiovascular disease. The growing inadequacy of allogenic blood supply has also contributed to an increase in the size of this segment.

North America dominates the market and expects to continue doing so in the forecast period.

North America will dominate the overall market during the forecast period. Market growth can be attributed to critical factors like players and many regional surgeries. Also, the established healthcare infrastructure is a crucial factor. The market will grow due to positive government initiatives and increased awareness about auto-transfusion due to the lack of allogenic blood. The United States holds the largest share in this region due to its supportive healthcare policies and developed healthcare market. The American National Red Cross estimates that approximately 36,000 red blood cells are required daily in the United States. According to statistics, the market growth in the region is boosted by the growing demand for blood products and the rising disposable income.

Competitive Landscape

There are several prominent players in the Auto-transfusion Systems market. It is competitive. Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Haemonetics Corporation, Liva Nova PLC, Medtronic, Redax, Teleflex Incorporated, and Zimmer Biomet are some of the dominant players in the market.

Major Players

  1. Becton, Dickinson and Company
  2. Beijing ZKSK Technology Co., Ltd.
  3. Braile Biomedical
  4. Medtronic
  5. Zimmer Biomet


Table of Contents

    1. 1.1 Study Deliverables
    2. 1.2 Study Assumptions
    3. 1.3 Scope of the Study
    1. 4.1 Market Overview
    2. 4.2 Market Drivers
      1. 4.2.1 Increasing Number of Surgical Procedures
      2. 4.2.2 Scarcity of Donated Blood/Allogenic Blood
    3. 4.3 Market Restraints
      1. 4.3.1 High Costs Associated with Autotransfusion Systems
      2. 4.3.2 Risks Associated with Autotransfusion
    4. 4.4 Porter’s Five Force Analysis
      1. 4.4.1 Threat of New Entrants
      2. 4.4.2 Bargaining Power of Buyers/Consumers
      3. 4.4.3 Bargaining Power of Suppliers
      4. 4.4.4 Threat of Substitute Products
      5. 4.4.5 Intensity of Competitive Rivalry
    1. 5.1 By Product Type
      1. 5.1.1 Devices
      2. 5.1.2 Consumables
    2. 5.2 By Application
      1. 5.2.1 Cardiac Surgeries
      2. 5.2.2 Orthopedic Surgeries
      3. 5.2.3 Organ Transplantation
      4. 5.2.4 Others
    3. 5.3 By End-User
      1. 5.3.1 Hospitals
      2. 5.3.2 Ambulatory Surgical Centers
      3. 5.3.3 Others
    4. 5.4 Geography
      1. 5.4.1 North America
        1. United States
        2. Canada
        3. Mexico
      2. 5.4.2 Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. 5.4.3 Asia-Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      4. 5.4.4 Middle-East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle-East and Africa
      5. 5.4.5 South America
        1. Brazil
        2. Argentina
        3. Rest of South America
      1. 6.1 Company Profiles
        1. 6.1.1 Becton, Dickinson and Company
        2. 6.1.2 Beijing ZKSK Technology Co., Ltd.
        3. 6.1.3 Fresenius Kabi
        4. 6.1.4 Zimmer Biomet
        5. 6.1.5 Medtronic Plc
        6. 6.1.6 Liva Nova PLC
        7. 6.1.7 Redax Spa
        8. 6.1.8 Gen World Medical Devices
        9. 6.1.9 Haemonetics Corporation
        10. 6.1.10 Teleflex Incorporated
    *List Not Exhaustive

Major Segmentation

By Product Type
By Application
Cardiac Surgeries
Orthopedic Surgeries
Organ Transplantation
By End-User
Ambulatory Surgical Centers

Major Companies

  1. Becton, Dickinson and Company
  2. Beijing ZKSK Technology Co., Ltd.
  3. Braile Biomedical
  4. Medtronic
  5. Zimmer Biomet

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF